This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Efficacy of allogeneic hematopoietic cell transplantation in patients with chronic phase CML resistant or intolerant to tyrosine kinase inhibitors, Hematology/Oncology and Stem Cell Therapy, March 2021, King Faisal Specialist Hospital and Research Centre - DIGITAL COMMONS JOURNALS,
DOI: 10.1016/j.hemonc.2021.02.003.
You can read the full text:
The following have contributed to this page
